University of Patras
ΟΙ ΕΝΔΟΚΥΣΤΙΚΕΣ ΕΓΧΥΣΕΙΣ ΒΑΚΚΙΛΩΝ CALMETTE-GUERIN (BCG) ΣΤΗΝ ΠΡΟΦΥΛΑΚΤΙΚΗ ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΤΩΝ ΕΠΙΦΑΝΕΙΑΚΩΝ ΟΓΚΩΝ ΤΗΣ ΟΥΡΟΔΟΧΟΥ ΚΥΣΤΗΣ
Abstract
dc:descriptionA CONTROLLED RANDOMIZED PROSPECTIVE TRIAL ON 94 PATIENTS EVALUATED THE EFFICIENCY OF INTRAVESICAL B.C.G. ADMINISTRATION AS PROPHYLAXIS AGAINST TUMOR RECURRENCES. THE TREATMENT SCHEDULE CONSISTING OF AN INITIAL 6-WEEK COURSE OF INSTILLATIONS AND THEN A SINGLE MAINTENANCE DOSE AT EVERY FOLLOW-UP EXAMINATION (DONE AT EVERY THREE MONTHS DURING THE FIRST TWO YEARS AND EVERY SIX MONTHS THEREAFTER) WAS MODIFIED IN THOSE OF THE RESPONDERS (WHO DID NOT RECUR) WHO WERE IN HIGH RISK TO RECUR (HAVING STAGE T1, OR/AND GRADE 3 TUMORS, OR/AND MULTIPLE OR/AND RECURRENT NEOPLASMS AT PRESENTATION) AND WHO RECEIVED AN ADDITIONAL 4-WEEK COURSE OF INSTILLATIONS AT MONTH 6 OF FOLLOW UP. COMPARISONS BETWEEN THE TWO GROUPS OF PATIENTS REVEALED A SIGNIFICANT BENEFIT FOR BCG AS OVERALL AS FOR THOSE HAVING A HISTORY OF PREVIOUS TUMOR RECURRENCES , MULTIFOCAL DISEASE, STAGE TA AND T1 , GRADE 2 AND 2 NEOPLASMS, AS WELL AS TUMORS WEIGHING LESS THAN 3 GR. DRUG-INDUCED TOXICITY WAS ACCEPTABLE. THIS STUDY INDICATES THAT BCG WITH OUR MODIFIED PROTOCOL IS SAFE AND EFFECTIVE IN THE PREVENTION OF SUPERFICIAL BLADDER TUMOR RECURRENCE, EITHER IN LOW OR IN HIGH RISK FOR RECURRENCES PATIENTS.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 1994
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Πανταζάκος, Αθανάσιος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/2957